Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio... see more

Recent & Breaking News (TSX:DHT.UN)

DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints

Canada NewsWire 4 days ago

DRI Healthcare Trust Announces Appointment of Annalisa King to Board of Trustees and as Chair of the Audit Committee

Canada NewsWire 9 days ago

DRI Healthcare Trust Announces Voting Results of AGM

Canada NewsWire May 13, 2025

DRI Healthcare Trust Reports First Quarter 2025 Results and Announces Internalization of Manager

Canada NewsWire May 12, 2025

DRI Healthcare Trust to Host First Quarter 2025 Earnings Call and Webcast on May 13, 2025

Canada NewsWire April 22, 2025

Quarterly Cash Distribution Payment Date Adjustment Due to Canadian Statutory Holiday

Canada NewsWire March 5, 2025

DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results

Canada NewsWire March 3, 2025

DRI Healthcare Trust to Host Fourth Quarter and Full Year 2024 Earnings Call and Webcast on March 4, 2025

Canada NewsWire January 29, 2025

DRI Healthcare Trust Declares Special Unit Distribution

Canada NewsWire December 20, 2024

DRI Healthcare Trust Reports Third Quarter 2024 Results

Canada NewsWire November 6, 2024

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the Worldwide Sales of Sebetralstat for the Treatment of Hereditary Angioedema Plus an Equity Investment in KalVista Pharmaceuticals

Canada NewsWire November 4, 2024

DRI Healthcare Trust Announces Upsized US$631.6 Million Credit Facilities

Canada NewsWire November 1, 2024

DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 7, 2024

Canada NewsWire October 11, 2024

DRI Healthcare Trust Announces Acquisition of Payment Streams based on the Cas9 Gene-Editing Technology for CASGEVY® (exagamglogene autotemcel)

Canada NewsWire October 3, 2024

DRI Healthcare Trust Reports Second Quarter 2024 Results

Canada NewsWire August 6, 2024

Investor Alert: SMK Law Investigation into DRI Healthcare Trust (TSX: DHT.UN)

Business Wire July 11, 2024

Kalloghlian Myers LLP: Potential Investor Class Action Against DRI Healthcare Trust

Business Wire July 9, 2024

DRI Healthcare stock drops 28% after executive changes

Jocelyn Aspa July 8, 2024

DRI Healthcare Trust and DRI Capital Inc. Announce Executive Changes

Canada NewsWire July 8, 2024

DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 7, 2024

Canada NewsWire July 3, 2024